Pishvaian MJ, Lee MS, Ryoo B, et al. Updated safety and clinical activity results from a Phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC). ESMO 2018, abstract LBA26.
Is aanpassing van de bestralingsdosis mogelijk op basis van de genomische stralengevoeligheid van de tumor?
sep 2017 | Radiotherapie